These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15348021)

  • 21. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.
    Pitt CG; Gratzl MM; Jeffcoat AR; Zweidinger R; Schindler A
    J Pharm Sci; 1979 Dec; 68(12):1534-8. PubMed ID: 529046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro release of trypanocidal drugs from biodegradable implants based on poly(epsilon-caprolactone) and poly(D,L-lactide).
    Lemmouchi Y; Schacht E; Lootens C
    J Control Release; 1998 Oct; 55(1):79-85. PubMed ID: 9795018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
    Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
    J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation.
    Liu H; Finn N; Yates MZ
    Langmuir; 2005 Jan; 21(1):379-85. PubMed ID: 15620328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained release of mitomycin-C from poly(DL-lactide) /poly(DL-lactide-co-glycolide) films.
    Gümüşderelioglu M; Deniz G
    J Biomater Sci Polym Ed; 2000; 11(10):1039-50. PubMed ID: 11211156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
    Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
    Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics.
    Pistel KF; Bittner B; Koll H; Winter G; Kissel T
    J Control Release; 1999 Jun; 59(3):309-25. PubMed ID: 10332063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
    Matsumoto J; Nakada Y; Sakurai K; Nakamura T; Takahashi Y
    Int J Pharm; 1999 Aug; 185(1):93-101. PubMed ID: 10425369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery.
    Lautner G; Meyerhoff ME; Schwendeman SP
    J Control Release; 2016 Mar; 225():133-9. PubMed ID: 26763376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
    Kavas A; Keskin D; Altunbaş K; Tezcaner A
    Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and properties of poly(lactic acid).
    Andreopoulos AG; Hatzi E; Doxastakis M
    J Mater Sci Mater Med; 1999 Jan; 10(1):29-33. PubMed ID: 15347991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Fluorouracil delivery from a novel three-dimensional micro-device: in vitro and in vivo evaluation.
    Zheng N; Zhou M; Du C; Wang S; Lu W
    Arch Pharm Res; 2013 Dec; 36(12):1487-93. PubMed ID: 23775471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Williams JA; Dillehay LE; Tabassi K; Sipos E; Fahlman C; Brem H
    J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled DNA delivery systems.
    Luo D; Woodrow-Mumford K; Belcheva N; Saltzman WM
    Pharm Res; 1999 Aug; 16(8):1300-8. PubMed ID: 10468035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.